GE Healthcare (GE) Updates on Results from Two Phase 3s of [18F]flutemetamol
Go back to GE Healthcare (GE) Updates on Results from Two Phase 3s of [18F]flutemetamol| General Electric (NYSE: GE) | Delayed: 344.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $344.64 | 52 Week High | $33.00 | |||
| Open | $344.64 | 52 Week Low | $27.10 | |||
| Day High | $344.64 | P/E | 234.45 | |||
| Day Low | $344.64 | EPS | $1.47 | |||
| Volume | 11,264 | |||||

